IT1250366B - Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso. - Google Patents
Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso.Info
- Publication number
- IT1250366B IT1250366B ITTO911019A ITTO911019A IT1250366B IT 1250366 B IT1250366 B IT 1250366B IT TO911019 A ITTO911019 A IT TO911019A IT TO911019 A ITTO911019 A IT TO911019A IT 1250366 B IT1250366 B IT 1250366B
- Authority
- IT
- Italy
- Prior art keywords
- protein material
- recombinant
- protein
- same
- human cytomegalovirus
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 3
- 241000701024 Human betaherpesvirus 5 Species 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 239000013612 plasmid Substances 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Materiale proteico consistente in una proteina di fusione incorporante un determinante antigenico della proteina p52 del Citomegalovirus umano (HCMV), in particolare la sequenza carbossil-terminale degli ultimi 233 amminoacidi della proteina p52; il peptide è espresso da un plasmide ricombinante per introduzione dello stesso in E.coli e risulta fortemente reattivo verso IgM umane prodotte contro il Citomegalovirus durante la fase di infezione primaria; viene utilizzato, associato con antigeni tradizionali (virioni parzialmente purificati o cellule infette) e/o con altri peptidi sintetici o di fusione, come reagente antigenico in un kit ELISA per la ricerca di IgM HCMV- specifiche, oppure per la produzione di sieri policlonali monospecifici e/o di MaB anti-p52 del HCMV da utilizzare in kit diagnostici per il riconoscimento diretto dell'antigene virale.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO911019A IT1250366B (it) | 1991-12-23 | 1991-12-23 | Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO911019A IT1250366B (it) | 1991-12-23 | 1991-12-23 | Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITTO911019A0 ITTO911019A0 (it) | 1991-12-23 |
| ITTO911019A1 ITTO911019A1 (it) | 1993-06-23 |
| IT1250366B true IT1250366B (it) | 1995-04-07 |
Family
ID=11409821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITTO911019A IT1250366B (it) | 1991-12-23 | 1991-12-23 | Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso. |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1250366B (it) |
-
1991
- 1991-12-23 IT ITTO911019A patent/IT1250366B/it active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITTO911019A1 (it) | 1993-06-23 |
| ITTO911019A0 (it) | 1991-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2078694A1 (en) | Hepatitis b vaccine | |
| Landini et al. | Large-scale screening of human sera with cytomegalovirus recombinant antigens | |
| ES2232821T3 (es) | Mono- y poli-antigenos recombinados para la deteccion del igm especifico del citomegalovirus en los sueros humanos por dosificado inmuno-enzimatico. | |
| Rumpold et al. | The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). | |
| AU8849391A (en) | An augmented western blot format and immunoassay for detection of viral antibodies | |
| JP2574992B2 (ja) | モノクローナル抗体産生ハイブリドーマ細胞系 | |
| CA2057052A1 (en) | Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof | |
| AU707301B2 (en) | Epstein-Barr virus peptides and antibodies against these peptides | |
| AU7211591A (en) | Immunologically active peptides or polypeptides from the parvovirus b19 | |
| AU4439993A (en) | HCV peptide antigens and method of determining HCV | |
| US6197497B1 (en) | Immunoassay for herpes simplex virus | |
| Maine et al. | The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens | |
| IT1250367B (it) | Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico. | |
| EP0754755A3 (de) | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern | |
| ES2282847T3 (es) | Peptidos derivados del antigeno de la capside de vca-p18 del virus de epstein-barr y su uso. | |
| EP0985931A3 (en) | Recombinant antigen immunoassay for the diagnosis of syphilis | |
| EP1053248B1 (en) | Peptide structures and their use in diagnosis of herpes simplex virus type 2 | |
| Nuebling et al. | Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells | |
| Modrow et al. | Identification of a protein encoded in the EB-viral open reading frame BMRF 2 | |
| Welling-Wester et al. | Analogues of peptide 9–21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies | |
| JPH10511769A (ja) | 対応の抗体を検出することによりエプスタイン・バールウイルス原発性感染症を検査し得るペプチド試薬及びこのペプチド試薬を用いる方法 | |
| Kühn et al. | The use of Western blot procedures in the analysis of herpes simplex virus proteins | |
| WO2023164428A8 (en) | Recombinant antibodies comprising anti-human immunoglobulin g-invertase fusion proteins and methods of using the same | |
| Gan et al. | Distribution of Epstein‐Barr virus antigenic sites on the carboxyl terminal end of ribonucleotide reductase against nasopharyngeal carcinoma serum antibodies using an immunoabsorption method | |
| Fones-Tan | Cloning and expression of Epstein-Barr viral antigens in Escherichia coli: Purification of recombinant EBV antigens for diagnostic application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971218 |